Health Canada drug identification number

DIN 02399024 — BYSTOLIC 20 MG

BYSTOLIC is a tablet of Nebivolol marketed by ABBVIE CORPORATION. The full Nebivolol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02399024
Brand name
BYSTOLIC
Active ingredient
Nebivolol
Strength
20 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
ABBVIE CORPORATION
Health Canada status
MARKETED
Drug class
Cardioselective beta-1 adrenergic receptor blocker with vasodilating activity (antihypertensive agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Nebivolol products

DINBrandStrengthFormManufacturerStatus
02399016 BYSTOLIC 10 MG TABLET ABBVIE CORPORATION MARKETED
02398990 BYSTOLIC 2.5 MG TABLET ABBVIE CORPORATION MARKETED
02399008 BYSTOLIC 5 MG TABLET ABBVIE CORPORATION MARKETED
02543508 JAMP NEBIVOLOL 5 MG TABLET JAMP PHARMA CORPORATION MARKETED
02548720 PRZ-NEBIVOLOL 10 MG TABLET PHARMARIS CANADA INC MARKETED
02548704 PRZ-NEBIVOLOL 2.5 MG TABLET PHARMARIS CANADA INC MARKETED
02548739 PRZ-NEBIVOLOL 20 MG TABLET PHARMARIS CANADA INC MARKETED
02548712 PRZ-NEBIVOLOL 5 MG TABLET PHARMARIS CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.